ArticleGenetics2026
MateR: a novel genomic mating framework.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Balancing gain and diversity: Optimal contribution selection for sustainable genetic improvement in sugarcane.The plant genome · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Genomic mating uses genome-wide information to design crosses that maximize genetic gain while managing diversity. Expected gain is often predicted through the usefulness criterion, which depends on family means and variances. However, existing equations mix incompatible parameterizations when considering dominance effects. Furthermore, diversity control is often tuned with metrics that lack a direct link to the loss of additive variation and long-term gain. We derived equations that compute family mean and within-family variance consistently under breeding and genotypic parameterizations by computing locus-specific values using genotypic frequencies and propagating them to the entire genome through linkage disequilibrium covariances. We also developed a diversity metric that estimates the proportion of additive standard deviation lost and integrated both advances into the MateR software. We evaluated performance in simulated diploid and autotetraploid crop populations across multiple breeding schemes and against existing tools. The new equations predicted family means and variances with near-perfect accuracy when true QTL effects were known. With estimated marker effects, correlations were roughly 0.55-0.90 for family mean and about 0.25 for within-family standard deviation. The diversity metric matched the expected loss of additive standard deviation under random sampling and tracked loss of genic variance under selection. This framework unifies prediction of cross usefulness under dominance and supplies an interpretable diversity control directly tied to long-term gain. Implemented in MateR, it applies to diploids and autopolyploids and accommodates common breeding program constraints, including hybrid schemes and testers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.